loadpatents
name:-0.052067041397095
name:-0.056897878646851
name:-0.015421152114868
Lawrence; R. Michael Patent Filings

Lawrence; R. Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lawrence; R. Michael.The latest application filed is for "modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof".

Company Profile
16.51.47
  • Lawrence; R. Michael - Yardley PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Apelin receptor agonists and methods of use
Grant 11,390,616 - Meng , et al. July 19, 2
2022-07-19
Modified Relaxin Polypeptides Comprising A Pharmacokinetic Enhancer And Uses Thereof
App 20220211812 - Dubowchik; Gene M. ;   et al.
2022-07-07
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof
Grant 11,364,281 - Dubowchik , et al. June 21, 2
2022-06-21
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof
Grant 11,224,634 - Dubowchik , et al. January 18, 2
2022-01-18
Method of treating cardiovascular disease and heart failure with modified relaxin polypeptides
Grant 11,185,570 - Dubowchik , et al. November 30, 2
2021-11-30
Modified Relaxin Polypeptides Comprising A Pharmacokinetic Enhancer And Uses Thereof
App 20210196791 - Dubowchik; Gene M. ;   et al.
2021-07-01
Apelin Receptor Agonists And Methods Of Use
App 20210198246 - Meng; Wei ;   et al.
2021-07-01
Aryl Dihydropyridinones And Piperidinone Mgat2 Inhibitors
App 20210161869 - Turdi; Huji ;   et al.
2021-06-03
Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
Grant 10,966,967 - Turdi , et al. April 6, 2
2021-04-06
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation
Grant 10,822,343 - Banville , et al. November 3, 2
2020-11-03
Aryl Dihydropyridinones And Piperidinone Mgat2 Inhibitors
App 20200281905 - Turdi; Huji ;   et al.
2020-09-10
2-(1,1'-biphenyl)-1h-benzodimidazole Derivatives And Related Compounds As Apelin And Apj Agonists For Treating Cardiovascular Di
App 20200231547 - Su; Shun ;   et al.
2020-07-23
Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
Grant 10,695,328 - Turdi , et al.
2020-06-30
Heteroarylhydroxypyrimidinones as agonists of the APJ receptor
Grant 10,669,261 - Myers , et al.
2020-06-02
Imidazothiadiazole And Imidazopyrazine Derivatives As Protease Activated Receptor4 (par4) Inhibitors For Treating Platelet Aggre
App 20200123160 - Banville; Jacques ;   et al.
2020-04-23
6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists
Grant 10,590,113 - Pi , et al.
2020-03-17
Aryl Dihydropyridinones And Piperidinone Mgat2 Inhibitors
App 20190314346 - Turdi; Huji ;   et al.
2019-10-17
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation
Grant 10,428,077 - Banville , et al. October 1, 2
2019-10-01
4-hydroxy-3-(heteroaryl)pyridine-2-one Apj Agonists
App 20190263791 - Johnson; James A. ;   et al.
2019-08-29
2,4-dihydroxy-nicotinamides as APJ agonists
Grant 10,392,347 - Kim , et al. A
2019-08-27
Modified Relaxin Polypeptides Comprising A Pharmacokinetic Enhancer And Uses Thereof
App 20190256570 - Dubowchik; Gene M. ;   et al.
2019-08-22
Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
Grant 10,369,140 - Turdi , et al.
2019-08-06
Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
Grant 10,266,578 - Dubowchik , et al.
2019-04-23
6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides As Apj Agonists
App 20190002441 - Pi; Zulan ;   et al.
2019-01-03
Heteroarylhydroxypyrimidinones As Agonists Of The Apj Receptor
App 20180362508 - Myers; Michael C. ;   et al.
2018-12-20
Imidazothiadiazole And Imidazopyrazine Derivatives As Protease Activated Receptor4 (par4) Inhibitors For Treating Platelet Aggregation
App 20180305376 - Banville; Jacques ;   et al.
2018-10-25
6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists
Grant 10,106,528 - Pi , et al. October 23, 2
2018-10-23
2,4-dihydroxy-nicotinamides As Apj Agonists
App 20180297954 - Kim; Soong-Hoon ;   et al.
2018-10-18
4-hydroxy-3-(heteroaryl)pyridine-2-one Apj Agonists
App 20180273518 - Johnson; James A. ;   et al.
2018-09-27
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
Grant 10,047,103 - Banville , et al. August 14, 2
2018-08-14
Modified Relaxin Polypeptides Comprising A Pharmacokinetic Enhancer And Uses Thereof
App 20180222960 - DUBOWCHIK; Gene M. ;   et al.
2018-08-09
4-hydroxy-3-(heteroaryl)pyridine-2-one APJ agonists
Grant 10,011,594 - Johnson , et al. July 3, 2
2018-07-03
Aryl Dihydropyridinones And Piperidinone Mgat2 Inhibitors
App 20180133198 - Turdi; Huji ;   et al.
2018-05-17
Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
Grant 9,901,572 - Turdi , et al. February 27, 2
2018-02-27
Imidazothiadiazole derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
Grant 9,862,730 - Lawrence , et al. January 9, 2
2018-01-09
6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides As Apj Agonists
App 20170275272 - Pi; Zulan ;   et al.
2017-09-28
Imidazothiadiazole And Imidazopyrazine Derivatives As Protease Activated Receptor4 (par4) Inhibitors For Treating Platelet Aggregation
App 20170247395 - Banville; Jaques ;   et al.
2017-08-31
Aryl Dihydropyridinones And Piperidinone Mgat2 Inhibitors
App 20170216263 - Turdi; Huji ;   et al.
2017-08-03
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
Grant 9,688,695 - Banville , et al. June 27, 2
2017-06-27
Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
Grant 9,663,466 - Turdi , et al. May 30, 2
2017-05-30
Imidazothiadiazole and imidazopyridazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
Grant 9,518,064 - Martel , et al. December 13, 2
2016-12-13
4-hydroxy-3-(heteroaryl)pyridine-2-one Apj Agonists
App 20160355507 - Johnson; James A. ;   et al.
2016-12-08
Aryl Dihydropyridinones And Piperidinone Mgat2 Inhibitors
App 20160031816 - Turdi; Huji ;   et al.
2016-02-04
Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
Grant 9,249,096 - Abell , et al. February 2, 2
2016-02-02
Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
Grant 9,187,424 - Turdi , et al. November 17, 2
2015-11-17
Aryl Dihydropyridinones And Piperidinone Mgat2 Inhibitors
App 20150315144 - Turdi; Huji ;   et al.
2015-11-05
Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
Grant 9,120,794 - Abell , et al. September 1, 2
2015-09-01
Imidazothiadiazole Derivatives As Protease Activated Receptor 4 (par4) Inhibitors For Treating Platelet Aggregation
App 20150133446 - Lawrence; R. Michael ;   et al.
2015-05-14
Imidazothiadiazole And Imidazopyridazine Derivatives As Protease Activated Receptor 4 (par4) Inhibitors For Treating Platelet Aggregation
App 20150119390 - Martel; Alain ;   et al.
2015-04-30
Pyrrolinone Carboxamide Compounds Useful As Endothelial Lipase Inhibitors
App 20150105378 - Abell; Lynn ;   et al.
2015-04-16
Imidazothiadiazole And Imidazopyrazine Derivatives As Protease Activated Receptor 4 (par4) Inhibitors For Treating Platelet Aggregation
App 20150094297 - Banville; Jacques ;   et al.
2015-04-02
Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
Grant 8,952,180 - Abell , et al. February 10, 2
2015-02-10
Pyrrolinone Carboxamide Compounds Useful As Endothelial Lipase Inhibitors
App 20140221357 - Abell; Lynn ;   et al.
2014-08-07
Pyrrolinone Carboxamide Compounds Useful As Endothelial Lipase Inhibitors
App 20140213588 - Abell; Lynn ;   et al.
2014-07-31
Aryl dihydropyridinone and piperidinone MGAT2 inhibitors
Grant 8,791,091 - Turdi , et al. July 29, 2
2014-07-29
Heterocyclic CETP inhibitors
Grant 8,642,576 - Salvati , et al. February 4, 2
2014-02-04
Aryl Dihydropyridinone And Piperidinone Mgat2 Inhibitors
App 20130143843 - Turdi; Huji ;   et al.
2013-06-06
Heterocyclic Cetp Inhibitors
App 20120322761 - Salvati; Mark E. ;   et al.
2012-12-20
Triazolo compounds useful as DGAT1 inhibitors
Grant 8,324,241 - Huang , et al. December 4, 2
2012-12-04
Heterocyclic CETP inhibitors
Grant 8,304,403 - Salvati , et al. November 6, 2
2012-11-06
Amino-benzazoles as P2Y.sub.1 receptor inhibitors with pyridine ring and heterocyclic components
Grant 8,053,450 - Herpin , et al. November 8, 2
2011-11-08
Heterocyclic CETP inhibitors
Grant 7,888,376 - Salvati , et al. February 15, 2
2011-02-15
Triazolo Compounds Useful As Dgat1 Inhibitors
App 20110034468 - Huang; Yanting ;   et al.
2011-02-10
Heterocyclic Cetp Inhibitors
App 20100267669 - Salvati; Mark E. ;   et al.
2010-10-21
Linear urea mimics antagonists of P2Y.sub.1 receptor useful in the treatment of thrombotic condition
Grant 7,816,382 - Chao , et al. October 19, 2
2010-10-19
Heterocyclic CETP inhibitors
Grant 7,790,770 - Salvati , et al. September 7, 2
2010-09-07
Anthranilic acid derivatives as inhibitors of 17.beta.-hydroxysteroid dehydrogenase 3
Grant 7,569,725 - Kick , et al. August 4, 2
2009-08-04
Amino-benzazoles as P2Y.sub.1 receptor inhibitors
Grant 7,470,712 - Herpin , et al. December 30, 2
2008-12-30
Urea Antagonists Of P2y1 Receptor Useful In The Treatment Of Thrombotic Conditions
App 20080280905 - Chao; Hannguang J. ;   et al.
2008-11-13
Amino-benzazoles As P2y1 Receptor Inhibitors With Pyridine Ring And Heterocyclic Components
App 20080275090 - Herpin; Timothy F. ;   et al.
2008-11-06
Urea antagonists of P2Y.sub.1 receptor useful in the treatment of thrombotic conditions
Grant 7,388,021 - Chao , et al. June 17, 2
2008-06-17
Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method
Grant 7,265,145 - Dickson , et al. September 4, 2
2007-09-04
Heterocyclic Cetp Inhibitors
App 20070161685 - Salvati; Mark E. ;   et al.
2007-07-12
Heterocyclic Cetp Inhibitors
App 20070135631 - Salvati; Mark E. ;   et al.
2007-06-14
Linear urea mimics antagonists of P2Y1 receptor useful in the treatment of thrombotic condition
App 20070004677 - Chao; Hannguang J. ;   et al.
2007-01-04
Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same
Grant 7,067,525 - Yu , et al. June 27, 2
2006-06-27
Anthranilic acid derivatives as inhibitors of 17beta-hydroxysteroid dehydrogenase 3
App 20060135619 - Kick; Ellen K. ;   et al.
2006-06-22
Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
App 20060025403 - Yu; Guixue ;   et al.
2006-02-02
Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
Grant 6,979,691 - Yu , et al. December 27, 2
2005-12-27
Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
App 20050267119 - Chao, Hannguang J. ;   et al.
2005-12-01
Amino-benzazoles as P2Y1 receptor inhibitors
App 20050203146 - Herpin, Timothy F. ;   et al.
2005-09-15
Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method
App 20040259860 - Dickson, John K. ;   et al.
2004-12-23
Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
App 20040229882 - Yu, Guixue ;   et al.
2004-11-18
Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
Grant 6,713,487 - Yu , et al. March 30, 2
2004-03-30
Microsomal triglyceride transfer protein
App 20030166590 - Wetterau, John R. II ;   et al.
2003-09-04
Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
App 20030096827 - Yu, Guixue ;   et al.
2003-05-22
Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
App 20030092732 - Yu, Guixue ;   et al.
2003-05-15
Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
Grant 6,472,414 - Biller , et al. October 29, 2
2002-10-29
Nestable, modular apparatus for synthesis of multiple organic compounds
Grant 6,274,094 - Weller, III , et al. August 14, 2
2001-08-14
Inhibitors of microsomal triglyceride transfer protein and method
Grant 6,066,650 - Biller , et al. May 23, 2
2000-05-23
Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
Grant 5,760,246 - Biller , et al. June 2, 1
1998-06-02
Inhibitors of microsomal triglyceride transfer protein and method
Grant 5,739,135 - Biller , et al. April 14, 1
1998-04-14
.alpha.-phosphonosulfonate squalene synthetase inhibitors
Grant 5,712,396 - Magnin , et al. January 27, 1
1998-01-27
Inhibitors of microsomal triglyceride transfer protein and method
Grant 5,712,279 - Biller , et al. January 27, 1
1998-01-27
Nucleic acids encoding microsomal trigyceride transfer protein
Grant 5,595,872 - Wetterau, II , et al. January 21, 1
1997-01-21
Methods of preparing .alpha.-phosphonosulfinate squalene synthetase inhibitors
Grant 5,543,542 - Lawrence , et al. August 6, 1
1996-08-06
.alpha.-phosphonosulfinic squalene synthetase inhibitors
Grant 5,447,922 - Lawrence , et al. September 5, 1
1995-09-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed